Business Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd
ISIN : HK0000145638
Compare
Compare
Traded in other countries / regions
03613.Hong KongBJTRF.USATQR.Germany IPO Date
2013-05-23Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products, Mainland China (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Mainland China and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd, and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.05 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.19 | |||||
| Interest Coverage | 106.86 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 15.08 | |||||
| Beneish M-Score | -2.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year EBITDA Growth Rate | 0.3 | |||||
| 3-Year EPS without NRI Growth Rate | 0.8 | |||||
| 3-Year FCF Growth Rate | 62.1 | |||||
| 3-Year Book Growth Rate | 8.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.65 | |||||
| 9-Day RSI | 74.47 | |||||
| 14-Day RSI | 69.43 | |||||
| 6-1 Month Momentum % | -23.78 | |||||
| 12-1 Month Momentum % | -40.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.65 | |||||
| Quick Ratio | 8.59 | |||||
| Cash Ratio | 7.21 | |||||
| Days Inventory | 520.7 | |||||
| Days Sales Outstanding | 143.07 | |||||
| Days Payable | 115.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.24 | |||||
| Dividend Payout Ratio | 0.49 | |||||
| 3-Year Dividend Growth Rate | 12.8 | |||||
| Forward Dividend Yield % | 3.18 | |||||
| 5-Year Yield-on-Cost % | 5.27 | |||||
| Shareholder Yield % | 2.97 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.67 | |||||
| Operating Margin % | 41.89 | |||||
| Net Margin % | 35.44 | |||||
| FCF Margin % | 28.85 | |||||
| ROE % | 14.66 | |||||
| ROA % | 12.7 | |||||
| ROIC % | 32.84 | |||||
| ROC (Joel Greenblatt) % | 48.17 | |||||
| ROCE % | 17.74 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.63 | |||||
| PE Ratio without NRI | 15.16 | |||||
| Shiller PE Ratio | 15.71 | |||||
| Price-to-Owner-Earnings | 15.03 | |||||
| PEG Ratio | 7.22 | |||||
| PS Ratio | 5.58 | |||||
| PB Ratio | 2.2 | |||||
| Price-to-Tangible-Book | 2.28 | |||||
| Price-to-Free-Cash-Flow | 19.39 | |||||
| Price-to-Operating-Cash-Flow | 18.44 | |||||
| EV-to-EBIT | 9.41 | |||||
| EV-to-EBITDA | 9.41 | |||||
| EV-to-Revenue | 4.28 | |||||
| EV-to-FCF | 14.26 | |||||
| Price-to-Projected-FCF | 1.14 | |||||
| Price-to-DCF (Earnings Based) | 1.01 | |||||
| Price-to-DCF (FCF Based) | 0.64 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Graham-Number | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 2.63 | |||||
| Price-to-Net-Cash | 4.84 | |||||
| Earnings Yield (Greenblatt) % | 10.63 | |||||
| FCF Yield % | 5 | |||||
| Forward Rate of Return (Yacktman) % | 7.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Tong Ren Tang Chinese Medicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 179.394 | ||
| EPS (TTM) (€) | 0.077 | ||
| Beta | 0.08 | ||
| Volatility % | 26.41 | ||
| 14-Day RSI | 69.43 | ||
| 14-Day ATR (€) | 0.01901 | ||
| 20-Day SMA (€) | 1.111 | ||
| 12-1 Month Momentum % | -40.44 | ||
| 52-Week Range (€) | 1.03 - 1.89 | ||
| Shares Outstanding (Mil) | 837.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Tong Ren Tang Chinese Medicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Tong Ren Tang Chinese Medicine Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Tong Ren Tang Chinese Medicine Co Ltd Frequently Asked Questions
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR)'s stock price today?
The current price of FRA:TQR is €1.21. The 52 week high of FRA:TQR is €1.89 and 52 week low is €1.03.
When is next earnings date of Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR)?
The next earnings date of Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR) is .
Does Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR) is 3.24% (As of Today), Highest Dividend Payout Ratio of Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR) was 0.49. The lowest was 0.23. And the median was 0.3. The  Forward Dividend Yield % of Beijing Tong Ren Tang Chinese Medicine Co Ltd(FRA:TQR) is 3.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers